Table 1 Demographic and clinical information regarding the 25,063 thyroid cancer patients that met the requirements for the main modelling phase.
Patients | Alive | COD-TC | |||||
|---|---|---|---|---|---|---|---|
Number of participants (% of total) | 24,025 (95.9%) | 1,038 (4.1%) | |||||
Gender (male/female; % of each) | 4,896/19,129 (20.4%/79.6%) | 426/612 (41.0%/59.0%) | |||||
Race (white/black/American Indian, Alaska Native, Asian, Pacific Islander/unknown; % of each) | 19,774/1,295/2,777/179 (82.3%/5.4%/11.6%/0.7%) | 829/70/137/2 (79.9%/6.7%/13.2%/0.2%) | |||||
Grade (I (well differentiated)/II (moderately differentiated)/III (poorly differentiated)) | 3,671/1,143/175 (grades for remaining cases were unrecorded) | 75/69/189 (grades for remaining cases were unrecorded) | |||||
Age ± standard deviation | 40.5 ± 12.8 | 65.9 ± 13.4 | |||||
Age groups (top); proportion of each group (Alive/COD-TC) in % (bottom) | 20–29 | 30–39 | 40–49 | 50–59 | 60–69 | 70–79 | ≥80 |
16/0.8 | 28/1.8 | 27/7.3 | 17/17 | 7.2/22 | 2.9/29 | 0.3/22 | |
